Kwality Pharmaceuticals Schedules Board Meeting to Approve Q2 Results
Kwality Pharmaceuticals Ltd 路 Intimation 路 12 Nov 2026, 5:30 am
Kwality Pharmaceuticals Schedules Board Meeting to Approve Q2 Results Kwality Pharmaceuticals Limited announced that its Board of Directors will meet on 12th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. Additionally, pursuant to insider trading regulations, the trading window for dealing in company securities remains closed for designated persons, their immediate relatives, and connected persons until 48 hours after the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Kwality Pharmaceuticals Ltd
- Transcript of Earnings Conference Call - Q2FY2027 路 16 Nov 2026
- Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Recording of Investor/ Analyst Earnings Call held on November 13, 2026 路 14 Nov 2026
- Intimation under Regulation 30 of the SEBI(LODR), 2015 -Recording of Investor/ Analyst Earnings Call held on September 13, 2026 路 14 Nov 2026
- Investor Presentation for the quarter and half year ended unaudited financial results for 30-09-2026 路 12 Nov 2026
- Appointment of new Statutory Auditors 路 12 Nov 2026
- Resignation of Statutory Auditor 路 12 Nov 2026
- Approval of Unaudited Financial Results for the quarter and half year ended 30-09-2026. 路 12 Nov 2026
- Approval of Unaudited Financial Results for the quarter and half year ended 30-09-2026 路 12 Nov 2026
